As the U.S. Food and Drug Administration (FDA) seeks to modernise its regulatory processes,...
Balancing Enforcement and Innovation: CTP’s Post-RIF Strategy in Focus
As the U.S. Food and Drug Administration’s Center for Tobacco Products (CTP) adjusts to a new era of leadership and reduced staffing, a clearer regulatory direction is beginning to emerge. Following months of internal restructuring and uncertainty,...
Results - 55 Blogs
Since January 2025, the regulatory landscape for tobacco and nicotine products in the United States...
When developing a nicotine product, the choice between freebase nicotine and nicotine salts plays a...
Chromatography is a cornerstone of analytical testing for nicotine products. It allows us to...
Why MMAD Testing Matters in Inhalation Product Development
Bringing a medical device to market isn’t just about innovation—it’s about precision, compliance,...
Introduction: Preparing for Regulatory Change in the Vape Industry
As global economic dynamics shift, the reduced-risk nicotine industry, already contending with...
The UK heated tobacco market continues to evolve rapidly, with growing consumer interest and an...
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
